A 3D pancreatic tumor model to study T cell infiltration
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
3D PDAC-TME model to observe and quantify T cell infiltration across the vasculature. In a three-channel microfluidic device, PDAC cells are cultured in a collagen matrix in the central channel surrounded, on one side, by endothelial cells (ECs) to mimic a blood vessel and, on the opposite side, by pancreatic stellate cells (PSCs) to simulate exocrine pancreas. The migration of T cells toward the tumor is quantified based on their activation state and TME composition. The presence of EC-lining drastically reduces T cell infiltration, confirming the essential role of the vasculature in controlling T cell trafficking. We show that activated T cells migrate ∼50% more than the not-activated ones toward the cancer cells. Correspondingly, in the absence of cancer cells, both activated and not-activated T cells present similar migration toward the PSCs. The proposed approach could help researchers in testing and optimizing immunotherapies for pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In contrast, co-culturing PDAC cells with PSCs markedly increased T cell infiltration, emphasizing the influence of the TME on immune cell behavior.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“| PDAC | Mollica et al. (2021) | Microfluidic device with 2 lateral channels and central chamber | ECs, PSCs, Panc-1 PDAC cells, and T cells | EC barrier decreases T cell infiltration into PSCs + Panc-1 |”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al. (2021)
The cited source says what the claim attributes to it.
In the citing paper
“This innovative model employs a three-channel microfluidic device wherein PDAC cells are cultured in a central collagen matrix, bordered by ECs mimicking blood vessels on one side and pancreatic stellate cells (PSCs) simulating the exocrine pancreas on the other.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“The model facilitated the observation and quantification of T cell infiltration across the vasculature, offering insights into how TME composition influences T cell migration.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“To investigate T cell infiltration, an integral aspect of anti-tumor immune responses in PDAC, researchers developed a 3D in vitro PDAC-TME model (Mollica et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Mollica et al., 2021
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
Smith-Garvin, J. E., Koretzky, G. A., & Jordan, M. S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132706 · Cited by 2,144
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Research works printed but not linked: 4
- Boyiadzis, 2018, J. Immunother. Cancer, 6, 1
- Dirkx, 2003, Cancer Res., 63, 2322
- G.Adriani , A.Pavesi and R. D.Kamm , in Methods in Cell Biology , ed. J. Doh , D. Fletcher and M. Piel , Elsevier , 2018 , vol. 146 , p. 199
- Agliari, 2014, Sci. Rep., 4, 1
Cited by
Biomaterial-based platforms for tumour tissue engineering
Curvello, R., Kast, V., Ordóñez‐Morán, P., Mata, Á., & Loessner, D. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00535-3 · Cited by 87
Next generation organoid engineering to replace animals in cancer drug testing
Hockney, S., Parker, J., Turner, J. E., Todd, X., Todryk, S. M., Gieling, R. G., Hilgen, G., Simoes, D. C. M., & Pal, D. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115586 · Cited by 58
“Modelling immunotherapy in vitro requires creating an overlap between the lymphoid tissues in which immune responses develop, the cancer tissues in which the resulting immune responses need to act against the tumour cells, and the vessels that transport the immune cells between the two [104,105].”
BackgroundRavi, K., Manoharan, T. J. M., Wang, K.-C., Pockaj, B. A., & Nikkhah, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122428 · Cited by 47
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors
Liu, H., Noguera-Ortega, E., Dong, X., Lee, W. D., Chang, J., Aday, S., Li, Y., Shin, Y., Shi, X., Liousia, M., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02845-z · Cited by 55
“…flexibility and precise experimental control afforded by micro-fabricated cell culture devices to create specialized in vitro models, termed tumor-on-a-chip, that can more accurately emulate human solid malignancies and their local environment during CAR-T and other adoptive cell therapies 24–28 .”
Recent advances in vascularized tumor-on-a-chip
Huang, C. B. X., & Tu, T.-Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150332 · Cited by 34
“(42) investigated T-cell infiltration into the pancreatic cancer TME comprising Panc-1 cells, pancreatic stellate cells, and HUVECs, each seeded in different microfluidic channels.”
BackgroundActivation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity
Chamma, H., Vila, I. K., Taffoni, C., Turtoï, A., & Laguette, N. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215694 · Cited by 36
Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions
Visalakshan, R. M., Lowrey, M. K., Sousa, M. G. C., Helms, H. R., Samiea, A., Schutt, C. E., Moreau, J. M., & Bertassoni, L. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162905 · Cited by 35
Giustarini, G., Teng, G., Pavesi, A., & Adriani, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1156769 · Cited by 33
“More broadly, PANC-1 spheroids could be helpful in functional assays of T and myeloid cell infiltration (68, 69) to observe if the tumor spheroids induce chemotaxis and immune responses similar to those observed in patients, as confinement, anergy, and immunosuppression.”
MethodSelf-citationCholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine
Polidoro, M. A., Ferrari, E., Soldani, C., Franceschini, B., Saladino, G., Rosina, A., Mainardi, A., D’Autilia, F., Pugliese, N., Costa, G., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100910 · Cited by 32
Manoharan, T. J. M., Ravi, K., Suresh, A. P., Acharya, A. P., & Nikkhah, M. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303658 · Cited by 28
Recent advances in microfluidic-based cancer immunotherapy-on-a-chip strategies
Ngo, T. K. N., Kuo, C., & Tu, T. (2023) · Biomicrofluidics · doi:10.1063/5.0108792 · Cited by 27
A Tumor Microenvironment Model of Pancreatic Cancer to Elucidate Responses toward Immunotherapy
Kast, V., Nadernezhad, A., Pette, D., Gabrielyan, A., Fusenig, M., Honselmann, K. C., Stange, D. E., Werner, C., & Loessner, D. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201907 · Cited by 35
Miller, C. P., Fung, M., Jaeger-Ruckstuhl, C. A., Xu, Y., Warren, E. H., Akilesh, S., & Tykodi, S. S. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100948 · Cited by 19
“Previous studies evaluated T-cell trafficking with engineered T cells targeting enforced HBV antigen expression or CD133 in hepatocellular HEPG2 cell aggregates [30,31, 44], or T-cell infiltration in pancreatic cancer aggregates [45].”
BackgroundMoon, H., Surianarayanan, N., Singh, T., & Han, B. (2023) · Biomicrofluidics · doi:10.1063/5.0179444 · Cited by 23
PDAC-on-chip for in vitro modeling of stromal and pancreatic cancer cell crosstalk
Sgarminato, V., Marasso, S. L., Cocuzza, M., Scordo, G., Ballesio, A., Ciardelli, G., & Tonda-Turo, C. (2023) · Biomaterials Science · doi:10.1039/d2bm00881e · Cited by 17
Chen, Y., Lee, K., Liao, H.-J., Sun, W.-L., Huang, W., Wang, Y., Chang, W., & Liu, C. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135409 · Cited by 17
Poljak, I., Chiappini, C., & Adriani, G. (2026) · Lab on a Chip · doi:10.1039/d5lc01060h · Cited by 17
Self-citationVasudevan, J., Vijayakumar, R., Reales‐Calderón, J. A., Lam, M. S. Y., Ow, J. R., Aw, J., Tan, D., Tan, A. T., Bertoletti, A., Adriani, G., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123175 · Cited by 16
Self-citationMicrophysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
3D in vitro modeling of the exocrine pancreatic unit using tomographic volumetric bioprinting
Sgarminato, V., Madrid-Wolff, J. A., Boniface, A., Ciardelli, G., Tonda‐Turo, C., & Moser, C. (2024) · Biofabrication · doi:10.1088/1758-5090/ad6d8d · Cited by 15
“Although recent works have shown the possibility of modeling the PDAC microenvironment in vitro [22, 23, 25, 28–33], the tumor-stroma inter-play remains arduous to replicate and monitor in functionally effective models [34–37].”
Dellaquila, A., Dujardin, C., Bao, C.-L., Chaumeton, C., Carré, A., Guilcher, C. L., Lam, F., & Simón-Yarza, T. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213636 · Cited by 9
Recapitulating the Cancer‐Immunity Cycle on a Chip
Lee, Y., Min, J., Kim, S., Park, W., Ko, J., & Jeon, N. L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401927 · Cited by 11
Moresi, F., Noto, F., Vasudevan, J., Bisteau, X., Adriani, G., & Pavesi, A. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500098 · Cited by 13
Self-citationReconstructing tumor tissues in 3D: From organoids to bioengineered niches
Kast, V., Navaee, F., Halvaei, M., Liebau, S., Azoitei, N., Breunig, M., Loskill, P., & Kleger, A. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.03.005 · Cited by 7
Rafik, S. T., Bakkalci, D., MacRobert, A. J., & Cheema, U. (2025) · FEBS Open Bio · doi:10.1002/2211-5463.70018 · Cited by 8
Chen, X., Xie, Y., Sun, W. F., Ning, K., Chen, Y., Feng, L., Fang, C., Li, Y., & Yu, L. D. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.114317 · Cited by 3
Tumor Immune Engineering: Developing In Vitro Assays to Understand the Tumor–Immune Crosstalk
Iyer, R. N., Vartak, M., & Dey, T. (2025) · Advanced Biology · doi:10.1002/adbi.202400735 · Cited by 4
Engineering cancer avatars with microfluidics, biofabrication and biosensors
Martins, A. S., Piñeiro, R., Diéguez, L., Reis, R. L., & Caballero, D. (2026) · Biofabrication · doi:10.1088/1758-5090/ae62aa · Cited by 3
Advanced 3D cancer models for analyzing tumor-immune cell interaction and therapeutic response
Jeevanandan, S. P., Reidy, E., Clegg, J., Curvello, R., Ryan, A. E., & Loessner, D. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02681-y · Cited by 2
“The stromal barrier also impaired T cell function and promoted cancer cell proliferation, high-lighting their role in T cell activation [119].”
InfluentialLi, Z., Zhu, X., Xu, Z., Tian, H., Wu, D., & Dai, X. (2026) · International Journal of Bioprinting · doi:10.36922/ijb026180162 · Cited by 1
Pugh-Toole, M., Dawe, N., Smith, A., Boudreau, J. E., & Leung, B. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.08.511443 · Cited by 1
Giustarini, G., Ang, K. S., Kumar, P., Teng, G., Xi, B. K. Z., Tan, C. X., Bhalla, R., Kalaitsidou, E., Tay, A., Howland, S. W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.05.709702 · Cited by 2
Self-citationBiomaterial-based Platforms for Modeling the Pre-metastatic Niche
Halim, M. S. A., Nadernezhad, A., Kopecky, C., Hauser, S., Kilian, K. A., & Loessner, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30151-3.00005-x
Ozeer, F. Z., & Kester, J. C. (2026) · Nutrients · doi:10.3390/nu18132113
“By experimenting with different combinations of chambers, it was found that endothelial cells in the multi-culture system inhibited T-cell infiltration regardless of activation, a consideration critical to prevent overestimation and failure in clinical trials [53].”
Polidoro, M., Ferrari, E., Soldani, C., Franceschini, B., Saladino, G., Rosina, A., Mainardi, A., D’Autilia, F., Pugliese, N., Costa, G., et al. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10677492
Metadata
- Authors
- Mollica, H., Teo, Y. J., Tan, A. S. M., Tan, D. Z. M., Decuzzi, P., Pavesi, A., & Adriani, G.
- Affiliations
- Italian Institute of Technology (IT)
- Agency for Science, Technology and Research (SG)
- Corresponding author
- Adriani, Giulia
- ORCID
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 9
- Issue
- 22
- Pages
- 7420-7431
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W3210582147
- Cited by
- 32
- References
- 68
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 12 · 2022: 4
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biomaterials Science (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc)
- Funders
- Biomedical Research Council
- National Research Foundation Singapore (NRF2017-SISFP09)
- Agency for Science, Technology and Research
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- pancreatic ductal adenocarcinoma, T cell infiltration, tumor microenvironment, 3D tumor models, microfluidics, collagen matrix, endothelial cells, pancreatic stellate cells, T cell migration, T cell activation, vascular system
- MeSH terms
- Humans, Pancreatic Neoplasms, T-Lymphocytes, Carcinoma, Pancreatic Ductal, Endothelial Cells, Pancreatic Stellate Cells, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.